• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Q-Linea

20.20 SEK

+5.21 %

Less than 1K followers

QLINEA

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+5.21 %
+20.60 %
-14.04 %
-19.01 %
-17.08 %
-55.76 %
-94.87 %
-99.90 %
-99.77 %

Q-Linea operates in the medical technology sector. The company specializes in research and development of instruments and consumables. The products are mainly used in the treatment of infectious diseases and blood poisoning, and include diagnostic and analytical tools, as well as basic sample handling. The technology is based on the so-called ID and AST technology. Q-Linea was founded in 2008 and is headquartered in Uppsala.

Read more
Market cap
382.77M SEK
Turnover
320.03K SEK
Revenue
11.1M
EBIT %
-1,591.8 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
10.7
2026

Interim report Q2'26

30.10
2026

Interim report Q3'26

All
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release5/29/2026, 11:01 AM

Annika Blondeau Henriksson new interim CFO

Q-Linea
Regulatory press release5/27/2026, 5:50 PM

BULLETIN FROM ANNUAL GENERAL MEETING IN Q-LINEA AB (PUBL)

Q-Linea
Q-Linea, Audiocast, Q1'26
Webcast4/30/2026, 11:00 AM

Q-Linea, Audiocast, Q1'26

Q-Linea

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release4/30/2026, 5:30 AM

Interim report January - March 2026

Q-Linea
Regulatory press release4/27/2026, 5:05 PM

NOTICE OF ANNUAL GENERAL MEETING IN Q-LINEA AB (PUBL)

Q-Linea
Regulatory press release4/24/2026, 6:00 AM

Q-linea publish the Annual report for 2025

Q-Linea
Regulatory press release4/16/2026, 6:30 AM

Q-linea announces FDA clearance of expanded ASTar blood testing menu

Q-Linea
Press release4/2/2026, 6:45 AM

Q-linea announces shipment of two ASTar® instruments to Saudi Arabia

Q-Linea
Regulatory press release3/11/2026, 3:05 PM

The nomination committee's proposals to Q-linea’s annual general meeting 2026

Q-Linea
Press release2/5/2026, 9:54 AM

Redeye: Q-linea (Q4 Review) - Fewer contracts than expected, but KPIs pointing in the right direction

Q-Linea
Q-Linea, Audiocast, Q4'25
Webcast2/4/2026, 12:00 PM

Q-Linea, Audiocast, Q4'25

Q-Linea
Regulatory press release2/4/2026, 6:30 AM

Year-end report 1 January – 31 December 2025

Q-Linea
Press release1/19/2026, 10:00 AM

Large independent hospital in Southeastern United States adopts ASTar®

Q-Linea
Regulatory press release1/5/2026, 3:30 PM

Q-linea announces changes in US commercial leadership

Q-Linea
Press release12/30/2025, 9:00 AM

Q-linea signs first distribution agreement in South Asia

Q-Linea
Press release12/29/2025, 8:02 AM

Q-linea AB (publ) (OMX: QLINEA) today announces it will provide ASTar® to Italian users of the Accelerate Pheno rapid AST system

Q-Linea
Press release12/23/2025, 8:00 AM

Q-linea announces first two US hospital systems’ clinical implementation of ASTar®

Q-Linea
Regulatory press release11/28/2025, 10:00 AM

New number of shares and votes in Q-linea AB (publ)

Q-Linea
Regulatory press release11/20/2025, 3:45 PM

Q-linea announces new organisation and changes in executive leadership team

Q-Linea
Press release11/18/2025, 12:05 PM

Q-linea announces FDA submission for expanded claims for ASTar® BC G- panel

Q-Linea